8-KThe WireRoutine
Reg FD Disclosure · Company Update
Filed Dec 6, 2024 · 1y ago · Accession 0001193125-24-272559
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Stoke Therapeutics, Inc.
- Ticker
- STOK
- CIK
- 1623526
- Form type
- 8-K
- Filing date
- Dec 6, 2024
- Report date
- Dec 4, 2024
- Document
- d916273d8k.htm
- Size
- 278 KB